Your browser doesn't support javascript.
loading
Zinc Supplementation in Very Low Birth Weight Infants: A Randomized Controlled Trial.
Sahin, Suzan; Sari, Fatma N; Bidev, Duygu; Bozkurt, Ozlem; Dizdar, Evrim A; Oguz, Serife S.
Afiliación
  • Sahin S; Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Izmir Demokrasi University, Izmir, Turkey.
  • Sari FN; Division of Neonatology, Department of Pediatrics, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
  • Bidev D; Division of Neonatology, Department of Pediatrics, Koru Sincan Hospital, Ankara, Turkey.
  • Bozkurt O; Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Dizdar EA; Division of Neonatology, Department of Pediatrics, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
  • Oguz SS; Division of Neonatology, Department of Pediatrics, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Am J Perinatol ; 2023 Nov 08.
Article en En | MEDLINE | ID: mdl-37939725
ABSTRACT

OBJECTIVE:

Preterm infants have high zinc (Zn) requirements and are generally believed to be in a negative Zn balance in the early period of life. In this study, we aimed to investigate the effect of high-dose Zn supplementation in very low birth weight (VLBW infants with birth weight < 1.5 kg) infants on feeding intolerance and development of mortality and/or morbidities including necrotizing enterocolitis (NEC) and late-onset sepsis (LOS). STUDY

DESIGN:

This is a prospective randomized trial. VLBW preterm infants with gestational age of <32 weeks were randomly allocated on the seventh day of life to receive extra amount of supplemental Zn along with the enteral feedings (9 + 3 mg), besides regular low-dose supplementation (3 mg), from enrollment until discharge. Outcome measures were feeding intolerance, NEC (stage ≥ 2), LOS, and mortality.

RESULTS:

A total of 195 infants (97 from study group and 98 from control group) were analyzed. A total of 46 (47.4%) infants in the study group and 64 (65.3%) infants in the control group ended up with feeding intolerance (p = 0.012). NEC was observed in 11 infants (11.2%) in the control group and only 1 infant (1%) in the study group (p = 0.003). There was a negative correlation between high-dose Zn supplementation and number of culture-proven LOS episodes (p = 0.041). This significance was also present for clinical sepsis, being higher in the control group (p = 0.029). No relationship between high-dose Zn supplementation and mortality and other morbidities (hemodynamically significant patent ductus arteriosus, bronchopulmonary dysplasia, retinopathy of prematurity, and severe intraventricular hemorrhage) was observed.

CONCLUSION:

Zn supplementation for VLBW infants is found to be effective to decrease feeding intolerance, NEC, and LOS episodes in this vulnerable population. Current data support the supplementation of VLBW infants with higher than regular dose of Zn. KEY POINTS · Higher dose of Zn supplementation is shown to be a beneficial intervention in VLBW infants.. · Zn may decrease feeding intolerance, sepsis or NEC.. · Higher than regular dose of Zn seems to be safe..

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Perinatol Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Perinatol Año: 2023 Tipo del documento: Article País de afiliación: Turquía